Research

Neural

GLP-1 receptor agonists (GLP-1RAs) may have neuroprotective and neurotrophic effects in ALS models.

GLP-1RAs may be considered for further investigation in ALS treatment.

StrongSupportsmedium confidence
Preclinical studies suggest that GLP-1 signaling can provide neuroprotective and neurotrophic effects in ALS models.
Mohamed Mohsen Helal et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2026

Why this rating

Based on preclinical studies mentioned in the abstract.

Source

Targeting metabolic dysfunction in amyotrophic lateral sclerosis: therapeutic potential of GLP-1 receptor agonists

Mohamed Mohsen Helal et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2026

DOI 10.1080/21678421.2026.2627901

reviewCited 1×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →